Product Categories
Country: | United States |
---|---|
Tel: | 781-+1-781-999-5354 |
Mobile: | +1-00000000000 |
E-mail: | info@targetmol.com |
QQ: | |
Skype: | Chat Now! |
Address: | 36 Washington Street, Wellesley Hills |
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
Product Name | MF | CAS | Details |
---|
INCB054329 Racemate | C19H16N4O3 | 1628607-62-4 | Details |
Ilorasertib hydrochloride;ABT-348 hydrochloride | C25H22ClFN6O2S | 1847485-91-9 | Details |
INCB 3284 | C26H31F3N4O4 | 887401-92-5 | Details |
INCB 3284 dimesylate | C26H31F3N4O4 | 887401-93-6 | Details |
Impurity C of Calcitriol | C35H49N3O5 | 86307-44-0 | Details |
Impurity F of Calcipotriol | C39H68O3Si2 | 112875-61-3 | Details |
Impurity C of Alfacalcidol | C35H49N3O4 | 82266-85-1 | Details |
Imidaprilate;6366A;Imidaprilat | C18H23N3O6 | 89371-44-8 | Details |
Impurity B of Calcitriol;1β,25-Dihydroxyvitamin-D3;1-Epicalcitriol | C27H44O3 | 66791-71-7 | Details |
Imatinib-d8;STI571 D8;CGP-57148B D8;Imatinib D8 | C29H23N7OD8 | 1092942-82-9 | Details |
N-Desmethyl imatinib;Norimatinib;Imatinib metabolite N-Desmethyl imatinib | C28H29N7O | 404844-02-6 | Details |
Imatinib D4;STI571 D4;CGP-57148B D4 | C29H31N7O | 1134803-16-9 | Details |
Iloperidone metabolite Hydroxy Iloperidone;P88;Hydroxy Iloperidone | C24H29FN2O4 | 133454-55-4 | Details |
IL-17A antagonist 3 | C33H33ClN6O4 | 2230780-65-9 | Details |
IL-17A antagonist 1 | C33H41FN6O4 | 2205034-18-8 | Details |
IIIM-290 | C23H21Cl2NO5 | 2213468-64-3 | Details |
IL-15-IN-1 | C30H36N6O4S | 1831830-20-6 | Details |
IKK-IN-1 | C22H26ClN3O4 | 406211-06-1 | Details |
iFSP1 | C20H13N5 | 150651-39-1 | Details |
IFN alpha-IFNAR-IN-1 hydrochloride | C18H18ClNS | 2070014-98-9 | Details |
IDO-IN-9 | C13H13BrFN7O3S | 1888378-12-8 | Details |
IFN alpha-IFNAR-IN-1 | C18H17NS | 844882-93-5 | Details |
Betamethasone valerate;Betnovate;Luxiq;Betaderm;Betamethasone 17-valerate | C27H37FO6 | 2152-44-5 | Details |
Ifenprodil glucuronide | C27H35NO8 | 66516-92-5 | Details |
IACS-8968 S-enantiomer;IDO/TDO Inhibitor (S-enantiomer) | C17H18F3N5O2 | 2239305-70-3 | Details |
IACS-8968 R-enantiomer;IDO/TDO Inhibitor (R-enantiomer) | C17H18F3N5O2 | 2239305-67-8 | Details |
IDO1 and HDAC1 Inhibitor | C25H22BrFN8O4 | 2227044-16-6 | Details |
IACS-8968;IDO/TDO Inhibitor | C17H18F3N5O2 | 2144425-14-7 | Details |
IDO1-IN-2 | C15H17FN6O4 | 2346614-58-0 | Details |
IDO/TDO-IN-1 | C25H24FN5 | 2033173-01-0 | Details |
IDO-IN-6;NLG-1486 | C18H21FN2O2 | 1402837-76-6 | Details |
IDO-IN-8;NLG-1487 | C18H21FN2O2 | 1402837-77-7 | Details |
Acipimox;K-9321;Olbemox | C6H6N2O3 | 51037-30-0 | Details |
IDO-IN-4 | C26H35N3O3 | 1629125-65-0 | Details |
IDO-IN-11 | C19H23BrFN7O4S | 1888378-32-2 | Details |
IDO-IN-5;NLG-1489 | C18H21FN2O2 | 1402837-79-9 | Details |
IDO-IN-3 | C11H12BrFN6O2 | 2070018-30-1 | Details |
IDO-IN-12 | C13H11BrFN5O3S | 1888341-29-4 | Details |
IDO-IN-13;GS-4361 | C26H17F3N4O | 2291164-02-6 | Details |
IDH1 Inhibitor 3 | C31H25F4N5O3 | 2171081-24-4 | Details |
IDH1 Inhibitor 1 | C20H18F4N6O2 | 2234285-81-3 | Details |
IDH1 Inhibitor 2 | C26H22N4O | 2244895-42-7 | Details |
Idelalisib D5;CAL-101 D5;GS-1101 D5 | C22H18FN7O | 1830330-31-8 | Details |
Prothionamide;Protionamide;1321-TH | C9H12N2S | 14222-60-7 | Details |
Epanolol;Visacor;ICI141292 | C20H23N3O4 | 86880-51-5 | Details |
ICI 153110 | C11H11N3O | 87164-90-7 | Details |
FASN-IN-3 | C24H24N4O | 2097262-60-5 | Details |
Hexyl gallate;Gallic acid hexyl ester;Hexyl 3,4,5-trihydroxybenzoate | C13H18O5 | 1087-26-9 | Details |
HG-12-6 | C29H27F3N6O2S | 2222354-57-4 | Details |
hGPR91 antagonist 1 | C31H23F4N3O | 1314796-00-3 | Details |
Palonosetron hydrochloride;Palonosetron HCl;RS 25259 197;RS 25259 | C19H25ClN2O | 135729-62-3 | Details |
HIF-2α-IN-3 | C12H6ClN5O5 | 313964-19-1 | Details |
HIF-2α-IN-2 | C17H13F2NO4S | 1672666-82-8 | Details |
Histone Acetyltransferase Inhibitor II | C20H16Br2O3 | 932749-62-7 | Details |
HIV-1 integrase inhibitor 7 | C30H26O16 | 204268-03-1 | Details |
HIV-1 inhibitor-3 | C9H10F2N2O5 | 1612841-22-1 | Details |
HIV-1 integrase inhibitor | C11H9N3O4 | 544467-07-4 | Details |
HS80 | C19H22N4S | 2138838-57-8 | Details |
HSL-IN-1 | C19H13BClF3N2O4 | 2095156-13-9 | Details |
BAY 59-9435;HSL-IN-2 | C14H22N2O3 | 654059-21-9 | Details |
Encequidar mesylate;HM30181 mesylate;HM30181A mesylate | C39H40N6O10S | 849675-87-2 | Details |
HSL-IN-3;Ethyl 2-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)benzoate;HSL inhibitor 3 | C14H19BO4 | 346656-34-6 | Details |
Phenoxybenzamine hydrochloride;Phenoxybenzamine HCl;NSC 37448;NCI-c01661 | C18H22ClNO.ClH | 63-92-3 | Details |
Heme Oxygenase-1-IN-1;HO-1-IN-1 | C13H15BrN2 | 1093058-52-6 | Details |
Heme Oxygenase-1-IN-1 hydrochloride;HO-1-IN-1 hydrochloride | C13H16BrClN2 | 1092851-70-1 | Details |
HSR6071 | C10H12N8O | 111374-21-1 | Details |
HSV-TK substrate | C11H15N5O4 | 111687-37-7 | Details |
HWL-088 | C22H19FO4 | 2378617-96-8 | Details |
Hydroxy desmethyl Bosentan;Ro 64-1056 | C26H27N5O7S | 253688-62-9 | Details |
Hydroxy ziprasidone | C21H21ClN4O2S | 884305-08-2 | Details |
Hydroxyamine hydrochloride | NH2OH·HCl | 5470-11-1 | Details |
Hydroxybupropion | C13H18ClNO2 | 92264-81-8 | Details |
Hydroxycitric acid tripotassium hydrate;Potassium citrate monohydrate | C6H11KO8 | 6100-05-6 | Details |
Leflunomide;RS-34821;SU101;HWA486 | C12H9F3N2O2 | 75706-12-6 | Details |
(-)-Hydroxycitric acid;Garcinia acid | C6H8O8 | 27750-10-3 | Details |
Hydroxyzine D4 | C21H27ClN2O2 | 2070014-84-3 | Details |
Hydroxyzine D8 | C21H19ClD8N2O2 | 1189480-47-4 | Details |
I-OMe-Tyrphostin AG 538;I-OMe-AG 538 | C17H12INO5 | 1094048-77-7 | Details |
I2906 | C25H37N3O4 | 331963-29-2 | Details |
IACS-8779 | C21H25N9O10P2S2 | 2243079-26-5 | Details |
IACS-8803 | C20H23FN10O9P2S2 | 2095690-70-1 | Details |
IACS-9571;ASIS-P040 | C32H42N4O8S | 1800477-30-8 | Details |
IAXO-102 | C35H71NO5 | 1115270-63-7 | Details |
Ibiglustat (L-Malic acid);GZ402671 (L-Malic acid);Ibiglustat L-Malic acid;SAR402671 (L-Malic acid);Venglustat (L-Malic acid) | C24H30FN3O7S | 1629063-78-0 | Details |
Fusidic acid;Fusidine | C31H48O6 | 6990-06-3 | Details |
IBR2;Isoquinoline | C24H20N2O2S | 313526-24-8 | Details |
Ibrutinib-d5;PCI-32765 D5;Ibrutinib D5 | C25H24N6O2 | 1553977-17-5 | Details |
Ibrutinib dimer | C50H48N12O4 | 2031255-23-7 | Details |
Ibrutinib-MPEA | C32H39N9O2 | 1710768-30-1 | Details |
Ibuprofen-d3;(±)-Ibuprofen D3;Ibuprofen D3 | C13H15D3O2 | 121662-14-4 | Details |
(-)-Ibuprofenamide;(R)-Ibuprofenamide | C13H17NO3 | 121839-78-9 | Details |
ICI 118,551 hydrochloride;ICI 118551 hydrochloride | C17H28ClNO2 | 72795-01-8 | Details |
HL271 | C13H17ClF3N5O | 1422365-52-3 | Details |
HLY78;4-Ethyl-5-methyl-5,6-dihydro-[1,3]dioxolo[4,5-j]phenanthridine | C17H17NO2 | 854847-61-3 | Details |
Moxidectin;milbemycin B;CL301423 | C37 H53 N O8 | 113507-06-5 | Details |
HKI-357 | C31H29ClFN5O3 | 848133-17-5 | Details |
HIV-1 integrase inhibitor 4 | C24H20F2N4O5S | 1638504-66-1 | Details |
HIV-1 integrase inhibitor 3 | C21H22F2N4O4 | 1638504-56-9 | Details |
HPN-01 | C19H16ClN3O3S | 928655-63-4 | Details |
HS79 | C19H22N4S | 2138838-56-7 | Details |
Product Total: Product Page: | ||||
7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 |